FindTrial
Sign In

Multicenter cohort study of ANCA-associated vasculitis in China

Multicenter cohort study of ANCA-associated vasculitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056361
Enrollment
Unknown
Registered
2022-02-04
Start date
2022-02-14
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ANCA-associated vasculitis

Interventions

ANCA-associated vasculitis patients:none

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. As of March 31th, 2021, ANCA-associated vasculitis patients who had been hospitalized in renal division of participating centers; 2. Diagnosed with ANCA-associated vasculitis (primary or secondary diagnosis), according to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, i.e., microscopic polyangiitis (including renal-limited vasculitis), granulomatosis with polyangiitis, and eosinophilic granulomatosis with polyangiitis; 3. With available electronic medical records (the start date of baseline may vary by center).

Exclusion criteria

Exclusion criteria: 1. Secondary vasculitis which is secondary to (caused by) other disease; 2. Anti-GBM antibody (+); 3. Patients refuse to participate.

Design outcomes

Primary

MeasureTime frame
all-cause death;—

Secondary

MeasureTime frame
end-stage renal disease;diffuse alveolar hemorrhage;—

Countries

China

Contacts

Public ContactHuang Xiaoyan

Peking University Shenzhen Hospital

huangxiaoyan@pku.org.cn+86 13510782802

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026